Reach Us +32 466902153


Ethical considerations in relation to aspirin prophylaxis

Low-dose aspirin prophylaxis, 75–150 mg per day, reduces the risk of vascular events and there is also promising evidence that it may also reduce the risk of cancer. Increased use of aspirin may confer considerable benefits to the population, but the risk of causing a gastric bleed is certainly a major concern. There are ethical considerations related to the potential increased use of aspirin in the population. These include the balance of benefit and risk of the medicine, possible undesirable effects such as ‘risk compensation’ and ‘iatrogenesis’, as well as a potential impact on health inequalities. More research is therefore needed on aspirin, particularly to define and describe the population use of the drug. More evidence on aspirin, including an ongoing randomised controlled trial on vascular events, will allow appropriate policy responses to be made.


Gareth Morgan

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Flyer image
Abstracted/Indexed in
  • Index Copernicus
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Social care institute for Excellence(SCIE)
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Proquest Summons
  • MIAR
  • ResearchGate
  • University Grants Commission
  • Secret Search Engine Labs